RSV Pre-F0 protein (FITC,His tag)

N° du produit ABIN7488836

Protéine Recombinant RSV Pre-F0 exprimée dans HEK-293 Cells.

Aperçu rapide pour RSV Pre-F0 protein (FITC,His tag) (ABIN7488836)

Antigène: RSV Pre-F0

Type de proteíne: Recombinant

Origine: Human respiratory syncytial virus A

Source: HEK-293 Cells

Pureté: 90 %

Détail du produit

Purification/Conjugué: FITC,His tag

Fonction: FITC-Labeled Human respiratory syncytial virus A (strain A2) Pre-F0 Protein, His Tag

Séquence: Gln 26- Leu 513

Attributs du produit: FITC-Labeled Human respiratory syncytial virus A (strain A2) Pre-F0, His Tag is expressed from human 293 cells (HEK293). It contains AA Gln 26- Leu 513 (Accession # P03420).

niveau d'endotoxine: 1.0 EU per μg

Information d'application

Commentaires:

This protein carries a polyhistidine tag at the C-terminus. (FITC ,10xHis) The protein has a calculated MW of 56.1 kDa. The protein migrates as 60-65 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Buffer: PBS, pH 7.4

Stock: -20 °C

Stockage commentaire: -20°C, avoid light

Détail du antigène

Antigène: RSV Pre-F0

Sujet: Human respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. The RSV fusion glycoprotein (RSV F) is the principal target of RSV neutralizing antibodies in human sera. The RSV F is a type I viral fusion protein synthesized as inactive, single-chain polypeptides that assemble into trimers. RSV F fuses the viral and host cell membranes by irreversible protein refolding from the labile prefusion conformation to the stable post-fusion conformation. Both states exhibit epitopes targeted by neutralizing antibodies, and post-fusion RSV F is being developed as a vaccine candidate.

Poids moléculaire: 56.1 kDa